Howmet Aerospace Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Howmet Aerospace Inc trades at $225.87 (market cap $88.76B), while Relay Therapeutics Inc. Common Stock trades at $18.18 (market cap $3.82B). The key difference: Howmet Aerospace Inc is far larger — about 23.2× Relay Therapeutics Inc. Common Stock's market cap, and Howmet Aerospace Inc pays a 0.25% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Howmet Aerospace Inc for 35 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| HWM | RLAY | |
|---|---|---|
Market Cap | $88.76B | $3.82B |
Volume | 2,648,516 | 4,332,079 |
Sector | Industrials | Health |
52-Week High | $292.65 | $20.75 |
52-Week Low | $184.09 | $6.03 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $92.86B | $2.93B |
Dividend Yield | 0.25% | — |
Signals from Pluang's Aura AI — not financial advice
Howmet Aerospace (HWM) trades at $225.50, up 1.26% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains robust fundamentals with 20.52% net income margin and 34.89% ROE. Recent news highlights defense aerospace demand driving revenue growth, while institutional interest remains strong with Nykredit's $44.69 million investment in Q2 2026.
Outlook remains positive with 84% analyst buy ratings and $328.10 consensus price target suggesting 45% upside. Key risks include supply chain pressures and competitive threats from SpaceX's in-house initiatives. Earnings growth and defense contracts position HWM for sustained performance despite near-term technical weakness.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →